2024-05-15 09:12:27 ET
Summary
- B3's 1Q24 results were below market consensus, but revenue diversification offset the lower performance.
- Despite all the risks, the P/E multiple is half the industry average, which doesn't seem to make sense.
- The beginning of the US interest rate reduction cycle could improve B3's volumes and momentum.
Investment Thesis
I recommend buying B3 (NYSE: BOLSY ) shares. Despite the 1Q24 results coming in below market expectations, both in revenue and profit, they were offset by the company's revenue diversification....
Read the full article on Seeking Alpha
For further details see:
B3 Q1 2024: The Expected Recovery Has Not Yet Occurred